NHS trial indicates focal therapy reduces side effects in prostate cancer treatment

A 10-year NHS study of 3,500 patients demonstrates that focal therapy, a minimally invasive approach, significantly lowers side effects compared to traditional treatments. While the long-term oncological outcomes compared to radical surgery remain a subject of ongoing clinical evaluation, the findings suggest a potential shift in standard care protocols for localized prostate cancer.